Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Managing Editor Europe
UK
7+ years of experience
Scrip
By Kevin Grogan 16 Nov 2021
Having strongly made the case for Jardiance as a treatment for chronic heart failure, Boehringer Ingelheim and Eli Lilly believe the SGLT2 inhibitor could have a lot of potential in acute heart failure as well after promising data from the EMPULSE study.
Scrip
By Kevin Grogan 21 Jul 2021
Sales at the Swiss major have returned to around 80%-90% of their pre-pandemic levels, according to CFO Harry Kirsch after unveiling a healthy set of second-quarter financials.
Scrip
By Kevin Grogan 27 Nov 2020
As the coronavirus spreads beyond China, biopharma companies are taking precautions, with some more wary than others.
Topic China Coronavirus
Scrip
By Kevin Grogan 01 Jun 2020
Vas Narasimhan hopes that donations and the "unprecedented collaborations" between drugmakers trying to overcome the COVID-19 pandemic is leading to a shift in the perception of the value of the sector to society.
Topic Coronavirus
Scrip
By Kevin Grogan 30 Apr 2020
Bayer has beaten analyst forecasts for the first quarter but says the uncertainties brought about by the coronavirus pandemic prevent it from issuing financial guidance for the full year.
Topic Coronavirus Sales Earnings
Scrip
By Kevin Grogan 23 Oct 2019
Ketamine-Like Antidepressant Backed By CHMP If the nasal spray is approved by the European Commission, seven months after getting the green light in the US, Spravato will offer the first new mechanism of action in 30 years to treat major depressive disorder.
Scrip
By Kevin Grogan 14 May 2019
Scrip editors will dissect Q1 sales and earnings reports of top pharma companies and focus on key trends, developments, and projected future impact.
Scrip
By Kevin Grogan 07 Mar 2019
The German group believes it is going to be at the forefront of development in the cell and gene therapy space but is worried that Europe is failing to recognize the value that the pharma industry and its new technologies can create for society.
Topic Cell & Gene Therapy
Scrip
21 Jul 2022
Scrip
20 Jul 2022
Scrip
19 Jul 2022
Scrip
19 Jul 2022
Scrip
18 Jul 2022
Scrip
14 Jul 2022
Scrip
13 Jul 2022
Scrip
12 Jul 2022
Scrip
08 Jul 2022
Scrip
07 Jul 2022
Scrip
06 Jul 2022
Scrip
28 Jun 2022
Scrip
27 Jun 2022
Scrip
24 Jun 2022
Scrip
22 Jun 2022
